These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16273068)

  • 1. Biofilms strike back.
    O'Toole GA; Stewart PS
    Nat Biotechnol; 2005 Nov; 23(11):1378-9. PubMed ID: 16273068
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance.
    Landry RM; An D; Hupp JT; Singh PK; Parsek MR
    Mol Microbiol; 2006 Jan; 59(1):142-51. PubMed ID: 16359324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Foreign body infections--biofilms and quorum sensing].
    Høiby N; Johansen HK; Ciofu O; Jensen PØ; Bjarnsholt T; Givskov M
    Ugeskr Laeger; 2007 Nov; 169(48):4163-6. PubMed ID: 18211783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and resistance to imipenem of Pseudomonas aeruginosa on latex gloves.
    Ballesta S; Conejo MC; García I; Rodríguez-Martínez JM; Velasco C; Pascual A
    J Antimicrob Chemother; 2006 May; 57(5):1010-2. PubMed ID: 16531426
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms.
    Rodríguez-Martínez JM; Ballesta S; Pascual A
    Int J Antimicrob Agents; 2007 Oct; 30(4):366-8. PubMed ID: 17616359
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005.
    Oudhuis GJ; Verbon A; Hoogkamp-Korstanje JA; Stobberingh EE;
    Int J Antimicrob Agents; 2008 Jan; 31(1):58-63. PubMed ID: 17961989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa.
    Zeng Z; Qian L; Cao L; Tan H; Huang Y; Xue X; Shen Y; Zhou S
    Appl Microbiol Biotechnol; 2008 May; 79(1):119-26. PubMed ID: 18330563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
    Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture.
    Cross JL; Ramadan HH; Thomas JG
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):21-6. PubMed ID: 17599559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance.
    Peng X; Xu C; Ren H; Lin X; Wu L; Wang S
    J Proteome Res; 2005; 4(6):2257-65. PubMed ID: 16335974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on response of the metabolites in tricarboxylic acid cycle of Escherichi coli and Pseudomonas aeruginosa to antibiotic perturbation by capillary electrophoresis.
    Gao P; Shi C; Tian J; Shi X; Yuan K; Lu X; Xu G
    J Pharm Biomed Anal; 2007 May; 44(1):180-7. PubMed ID: 17403593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes.
    Pamp SJ; Gjermansen M; Johansen HK; Tolker-Nielsen T
    Mol Microbiol; 2008 Apr; 68(1):223-40. PubMed ID: 18312276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
    Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
    Toté K; Berghe DV; Deschacht M; de Wit K; Maes L; Cos P
    Int J Antimicrob Agents; 2009 Jun; 33(6):525-31. PubMed ID: 19179053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
    van der Plas MJ; Jukema GN; Wai SW; Dogterom-Ballering HC; Lagendijk EL; van Gulpen C; van Dissel JT; Bloemberg GV; Nibbering PH
    J Antimicrob Chemother; 2008 Jan; 61(1):117-22. PubMed ID: 17965032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.